Skip to main content

Table 3 Simulation results for the current cumulative incidence estimator and the Markov model estimator of Klein et al.

From: Estimation of current cumulative incidence of leukaemia-free patients and current leukaemia-free survival in chronic myeloid leukaemia in the era of modern pharmacotherapy

  Sample size 100 Sample size 1,000
  CCI estimator Markov model estimator CCI estimator Markov model estimator
Time         
  MAD* (%) Coverage of the 95% CI** (%) MAD* (%) Coverage of the 95% CI**(%) MAD* (%) Coverage of the 95% CI** (%) MAD* (%) Coverage of the 95% CI** (%)
1 year 3.7 93.8 3.7 92.8 1.1 95.4 1.1 95.2
2 years 3.2 94.7 3.2 94.4 1.0 94.4 1.0 94.5
3 years 3.1 94.3 3.1 94.2 1.0 95.2 1.0 95.2
4 years 3.2 95.0 3.2 94.3 1.0 95.4 1.0 95.1
5 years 3.6 95.4 3.6 94.7 1.0 93.7 1.0 94.7
6 years 3.6 95.7 3.6 94.5 1.2 92.9 1.2 94.2
7 years 4.2 94.6 4.0 94.0 1.2 95.9 1.2 96.2
8 years 4.8 95.5 4.7 93.4 1.5 94.9 1.4 94.8
9 years 5.7 92.9 5.7 90.4 1.6 95.3 1.6 95.6
10 years 6.4 92.3 6.4 87.3 2.0 94.1 1.9 94.9
  1. * Median absolute deviation between the estimated and true curve.
  2. ** The proportion of 95% point-wise confidence intervals that contained the approximated true curve.
Back to article page

BMC Medical Research Methodology

ISSN: 1471-2288

Contact us